Chelsea and Westminster Hospital pioneers autonomous artificial intelligence (AI) pathway for skin cancer to discharge harmless cases
Posted:
Chelsea and Westminster Hospital NHS Foundation Trust is utilising digital innovation and world-first autonomous technology to identify harmless (benign) skin lesions without review from the dermatology team, to be able to discharge patients on the same day as they receive their results.
This advanced AI skin cancer pathway helps clinicians and dermatologists effectively triage patients, enabling earlier detection.
Healthcare is evolving at an unprecedented pace. From artificial intelligence and digital transformation to integrated care and workforce innovation, the challenges facing the NHS and the wider healthcare sector require collaboration across every part of the ecosystem.
That's why healthcare…
If you're planning to attend GIANT Health Event 2026, now is the time to book.
Current Early Bird ticket prices are available for a limited time, but prices will increase soon as the event moves to the next ticket tier. Booking…
Attendees
Sponsors and Exhibitors
Contact us